黄色视频不卡_午夜福利免费观看在线_亚洲国产精品999在线_欧美绝顶高潮抽搐喷水_久久精品成人免费网站_晚上一个人看的免费电影_国产又色又爽无遮挡免费看_成人国产av品久久久

    1. <dd id="lgp98"></dd>
      • <dd id="lgp98"></dd>
        1. 上海起發(fā)實驗試劑有限公司

          線性聚乙烯亞胺PEI,硫酸葡聚糖 DSS

          化工儀器網(wǎng)收藏該商鋪

          15

          聯(lián)系電話

          15921799099

          您所在位置:
          上海起發(fā)實驗試劑有限公司>> Exocell 2015
           QQ交談
          產(chǎn)品展示

          Exocell 2015

          • 公司名稱:
          • 更新時間:
          • 所 在 地:
          • 生產(chǎn)地址:
          • 瀏覽次數(shù):
          • 上海起發(fā)實驗試劑有限公司
          • 2024-09-02 12:50:11
          • 上海市
          • 3001

          我要詢價

          【簡單介紹】

          Exocell代理,Exocell中國代理,Exocell上海代理,Exocell總代,Exocell
          Exocell專業(yè)代理-上海起發(fā)實驗試劑有限公司,具體產(chǎn)品信息歡迎電詢:4006551678

          【詳細(xì)說明】

          Exocell—糖尿病研究相關(guān)產(chǎn)品

          Exocell公司是一家專注于糖尿病及其并發(fā)癥研究相關(guān)的產(chǎn)品與服務(wù)美國高科技生物制品公司,該公司提供良好的糖尿病研究產(chǎn)品,涵蓋臨床診斷、臨床研究及基礎(chǔ)實驗研究領(lǐng)域,包括人、小鼠、 大鼠尿蛋白和糖基化蛋白,人纖連蛋白、載脂蛋白B等一系列試劑盒和抗體,其高品質(zhì)的產(chǎn)品歐美。作為開發(fā),營銷和執(zhí)行新的臨床診斷化驗*者,Exocell公司已經(jīng)并且正在為糖尿病及其相關(guān)的腎臟和血管疾病領(lǐng)域的基礎(chǔ)科研、實驗動物研究以及臨床診斷和治療研究提供優(yōu)質(zhì)的產(chǎn)品和研發(fā)服務(wù)。

                     

          Exocell公司的主要產(chǎn)品:

          一、臨床診斷檢測對于糖尿病及其并發(fā)癥的治療和管理至關(guān)重要,在該領(lǐng)域中Exocell公司提供的臨床診斷相關(guān)產(chǎn)品包括:

          Albuwell用于檢測微白蛋白尿,是早期糖尿病性腎功能紊亂的明確標(biāo)志物。

          Creatinine用于檢測尿中的creatinine.

          Glycaben用于監(jiān)測糖化白蛋白(中期的控糖指標(biāo))

          Glycacor用于檢測糖化LDL(短期控糖指標(biāo)及心血管疾病風(fēng)險指標(biāo))

          Hemoglobin A1c參照標(biāo)準(zhǔn)(長期控糖指標(biāo))


          二、臨床研發(fā)類檢測試劑與試劑盒測定大量人類糖尿病及其并發(fā)癥的重要指標(biāo),在該領(lǐng)域中Exocell公司提供的相關(guān)產(chǎn)品包括:

          Apo B Test用于檢測人血漿中的apolipoprotein B

          Collagen IV H用于檢測 樣本中的IV 型膠原

          hFibronectin ELISA試劑盒用于檢測人血漿中的fibronectin

          Nephrin ELISA試劑盒用于檢測尿液中的nephrin.

          h-PODXL用于檢測人組織或尿液樣本中的podocalyxin

          Beta-induced h3用于檢測人尿液中的BIG-H3,

          Troponin – H用于檢測人血漿或血清中的 Troponin I,

          TNF-sR2 用于檢測人尿/血漿/血清中的TNF-α可溶性受體2


          三、Exocell公司提供的糖尿病及其并發(fā)癥的實驗室研究相關(guān)產(chǎn)品,包括:

          Albuwell M用于檢測小鼠樣本中的微白蛋白尿,

          Nephrat II用于檢測大鼠樣本中的微白蛋白尿,

          Albuwell C, O  P 用于檢測狗、綿羊及非人的靈長類動物樣本中的微白蛋白尿,

          Collagen IV M用于檢測小鼠和大鼠樣本中的IV型膠原,

          Creatinine Companion用于檢測人和嚙齒類動物的creatinine.

          Glyco-Albumin R用于檢測大鼠血清中的糖化白蛋白,

          Nephrin ELISA to measure rodent urinary nephrin.

          CRP ELISA試劑盒用于檢測嚙齒類動物血漿中的C-reactive蛋白.

          Adiponectin ELISA試劑盒用于檢測人尿和血漿中的adiponectin,

          Beta-induced h3用于檢測人尿中的BIG-H3,

          Troponin M用于檢測小鼠血漿/血清中的Troponin I,

          Troponin R用于檢測大鼠血漿/血清中的Troponin I

          PODXL–R用于檢測嚙齒類動物尿液中的podpcalyxin ,


          四、糖尿病及其并發(fā)癥研究相關(guān)的試劑及標(biāo)準(zhǔn)參照品,包括高特異性的單克隆抗體及高度純化的蛋白,,在該領(lǐng)域中Exocell公司提供的相關(guān)產(chǎn)品包括:

          A717:抗糖化白蛋白單克隆抗體

          E85: 抗糖化血紅素的單克隆抗體

          ES12:抗糖化LDL的單克隆抗體

          糖化血紅素片段(gly Hb, HbA1c, glyHbA0, HbA1a, b)

          去糖的血紅素片段(degly Hb, degly HbA0)

          糖化的白蛋白(NGA/SGA)

          去糖化的白蛋白


          部分使用Exocell公司產(chǎn)品的相關(guān)文獻(xiàn):

            1、Albuwell M

          • American Journal Physiology Renal Physiology 293:F1657-1665, 2007
            Interference with TGF-B signalling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria
          • American Journal Physiology Renal Physiology 292:F321-329, 2007
            Soluble betaglycan reduces renal damage progression in db/db mice
          • Nephron Experimental Nephrology 105:e45-e52, 2007
            Amelioration of established diabetic nephropathy by combined treatment with SMP-534 (antifibrotic agent) and losartan in db/db mice
          • American Journal Physiology Renal Physiology 290:F214-F222, 2006
            Impact of genetic background on nephropathy in diabetic mice
          • American Journal Physiology Heart Circ Physiology 290:H935-H940, 2006
            Angiotensin II hypertension is attenuated in interleukin-6 knockout mice
          • American Journal Physiology Renal Physiology 291:F1315-F1322, 2006
            Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes
          • American Journal Physiology Renal Physiology 290:F813-820, 2006
            SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice
          • American Journal Physiology Renal Physiology 290:F828-F837, 2006
            Adenosine A2a receptor activation attenuates inflammation and injury in diabetic nephropathy
          • Nephron Experimental Nephrology 104:e23-e34, 2006
            Plasminogen activator inhibitor-1 deficiency has renal benefits but some adverse systemic consequences in diabetic mice
          • Journal American Society Nephrology 16:27-45, 2005
            Mouse models of diabetic nephropathy
          • American Society Nephrology 16:1289-1299, 2005
            Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23
          • Diabetes 54:2628-2637, 2005
            Characterization of susceptibility of inbred mouse strains to diabetic nephropathy
          • American Journal Pathology 165:1243-1255, 2004
            Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules
          • Hypertension 43:364-369, 2004
            Role for thromboxanes receptors in angiotensin-II-induced hypertension
          • Journal Clinical Investigation 113:1390-1397, 2004
            Induction of B7-1 in podocytes is associated with nephritic syndrome
          • Diabetes 53:2101-2109, 2004
            Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-?-deficient mice
          • Journal American Society Nephrology 14:1200-1211, 2003
            Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant ?-actinin-4
          • American Journal Pathology 162:1123-1137, 2003
            RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy
          • Kidney International 64:1978-1985, 2003
            Gene expression profile in diabetic KK/Ta mice
          • Journal of Immunology 170:5658-5666, 2003
            CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration

                2、Glycacor

          • Atherosclerosis 202:162-168, 2009
            Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro
          • Immunopharmacology Immunotoxicology 15:1-12, 2008
            Evaluation of serum biomarkers in nutritional disorders: Glycated apolipoprotein B, fasting serum glucose, fructosamine, stable and labile glycated hemoglobin in diabetic and non-diabetic subjects
          • Nutrition Metabolism & Cardiovascular Disease 17:6-12, 2007
            Glycated apolipoprotein B and myocardial infarction
          • Circulation 109:1750-1755, 2004
            Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes
          • Diabetes Technology & Therapeutics 6:348-356, 2004
            Increased plasma glycated low-density lipoprotein concentrations in diabetes: A marker of atherogenic risk
          • Journal American Society Nephrology 10:332-341, 1999
            Non-insulin dependent diabetes mellitus and hypertriglyceridemia impair lipoprotein metabolism in chronic hemodialysis patients
          • Nephrology Dialysis Transplantation 12:1336-1343, 1997
            Uptake and metabolism of lipoproteins from patients with diabetes mellitus type II by glomerular epithelial cells

          3、Nephrat

          • Cell Biochemistry Biophysics 48:147-157, 2007
            Novel inhibitors of glycation and AGE formation
          • American Journal Physiology Regul Integr Comp Physiology 292:R769-R777, 2007
            17-estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney
          • Diabetes 56:1842-1849, 2007
            Hyperglycemia is a major determinant of albumin permeability in diabetic microcirculation
          • American Journal Physiology Renal Physiology 290:F828-F837, 2006
            Adenosine A2a receptor activation attenuates inflammation and injury in diabetic nephropathy
          • Laboratory Investigation 86:357-368, 2006
            Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy
          • FASEB Journal 20:E150-E159, 2006
            Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers
          • American Journal Physiology Regul Integr Comp Physiology 290:R435-R441, 2006
            Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes
          • Laboratory Investigation 86:927-939, 2006
            Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy
          • American Journal Physiology Renal Physiology 289:F442-450, 2005
            Regulation of the renal thiazide-sensitive Na-Cl cotransporter, blood pressure, and natriuresis in obese Zucker rats treated with rosiglitazone
          • Diabetologia 46:1140-1152, 2003
            LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats
          • Journal American Society Nephrology 14:709-720, 2003
            Delayed treatment with lithospermate B attenuates experimental diabetic renal injury
          • Journal American Society Nephrology 14:3178-3187, 2003
            Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen ?5(IV) in experimental diabetic nephropathy and ion glucose-stimulated podocytes
          • American Journal Pathology 158:1733-1741, 2001
            A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis
          • American Journal Society Nephrology 12:993-1000, 2001
            Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes

                4、Collagen Type IV

          • Diabetologia 51:198-207, 2008
            Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells
          • Nephron Experimental Nephrology 105:e45-e52, 2007
            Amelioration of established diabetic nephropathy by combined treatment with SMP-534 (antifibrotic agent) and losartan in db/db mice
          • American Journal Physiology Renal Physiol 292:F789-F795, 2007
            Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency
          • American Journal Physiology Renal Physiology 290:F813-820, 2006
            SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice
          • Kidney International 68:1554-1561, 2005
            Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy
          • Kidney International 64:1632-1642, 2003
            Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells
          • Metabolism 50:1435-1440, 2001
            Increased urinary type IV collagen marks the development of glomerular [athology in diabetic db/db mice
          • Diabetes Care 24:914-918, 2001
            Increased collagen IV excretion in diabetes
          • Diabetes Care 24:1324-1327, 2001
            Serum type IV collagen in diabetic patients at risk for nephropathy

          5Nephrin

          • PLoS One 7(5):e36041, 2012
            Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: A cross sectional study
          • Am J Physiol Renal Physiol 302:F1084-F1089, 2012
            Increased urinary excretion of nephrin, podocalyxin and ?ig-h3 in women with preeclampsia

          6、Podocalyxin

          • Am J Physiol Renal Physiol 302:F1084-F1089, 2012
            Increased urinary excretion of nephrin, podocalyxin and βig-h3 in women with preeclampsia

          7、 βig-h3

          • Am J Physiol Renal Physiol 302:F1084-F1089, 2012
            Increased urinary excretion of nephrin, podocalyxin and βig-h3 in women with preeclampsia

          詳細(xì)公司及產(chǎn)品信息請訪問:http://www.exocell。。com/



          世界*實驗材料供應(yīng)商Exocell正式授權(quán)上海起發(fā)為其中國代理,Exocell在一直是行業(yè)的*,一直為廣大科研客戶提供zui為優(yōu)質(zhì)的產(chǎn)品和服務(wù),上海起發(fā)一直秉承為中國科研客戶帶來的產(chǎn)品,的服務(wù), 簽約Exocell就是為了給廣大科研客戶帶來更加完善的產(chǎn)品和服務(wù),您的滿意將是我們zui大的收獲

          Exocell中國代理,Exocell上海代理,Exocell北京代理,Exocell廣東代理,Exocell江蘇代理 Exocell湖北代理, Exocell天津, Exocell黑龍江代理, Exocell內(nèi)蒙古代理, Exocell吉林代理, Exocell福建代理, Exocell江蘇代理, Exocell浙江代理, Exocell四川代理,


          我們公司zui大優(yōu)勢是強(qiáng)大的采購,


          1:基本什么都能進(jìn)口,血清,抗體,耗材,還有部分限制進(jìn)口的,


          2 貨品全,現(xiàn)經(jīng)營過700多個品牌,基本所有生物試劑耗材都可以進(jìn)口,特別是冷偏的產(chǎn)品那就更有優(yōu)勢,


          3:提供加急服務(wù),一般1-2周到貨,超過時限加急費全免


          4:價格公道,絕大部分價格有優(yōu)勢,當(dāng)然不能保證100%產(chǎn)品都是,因為意味著沒有服務(wù).


          5:良好的信譽,大部分客戶我們提供貨到付款服務(wù),客戶包括清華,北大 交大 復(fù)旦,中山等100多所大學(xué),ROCHE,阿斯利康,國藥 ,fisher等500多家公司


          6:我們還是santa,Advanced Biotechnologies Inc;Athens Research & Technology, bangs, BBInternational, crystalchem, dianova, FD Neurotechnologies, Inc. FormuMax Scientific, Inc; Genebridege; Glycotope Biotechnology GmbH; iduron; Innovative Research of America; Ludger ; neuroprobe; omicronbio; Polysciences; prospecbi; QA-BIO;quickzyme;RESEARCH DIETS, INC;sterlitech;sysy;TriLink BioTechnologies, Inc;worthington-biochem;zyagen;......幾十家國外公司授權(quán)代理

          7:我們還從事invitrogen,qiagen; abcam ;sigma;neb; roche;merck; rnd; BD; GE; pierce; BioLegend....等*批發(fā)


              
          留言框
          感興趣的產(chǎn)品: *
          留言內(nèi)容:
          您的姓名: *
          您的單位:
          聯(lián)系電話: *
          微信:
          常用郵箱:
          詳細(xì)地址:
          省份: *
          驗證碼: * =   請輸入計算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
                

          相關(guān)產(chǎn)品

          產(chǎn)品搜索

          請輸入產(chǎn)品關(guān)鍵字:

          聯(lián)系方式
          地址:上海浦東川沙鎮(zhèn)川沙路6619號上海起發(fā)實驗試劑有限公司
          郵編:201203
          聯(lián)系人:楊經(jīng)理
          電話:021-50724187 021-50724961
          傳真:021-50724961
          手機(jī):15921799099
          留言:發(fā)送留言
          個性化:www.qfbio.com
          網(wǎng)址:www.qfbio.com
          商鋪:http://m.facexiu.com/st178406/
          | 商鋪首頁 | 公司檔案 | 產(chǎn)品展示 | 供應(yīng)信息 | 公司動態(tài) | 詢價留言 | 聯(lián)系我們 | 會員管理 |
          化工儀器網(wǎng) 設(shè)計制作,未經(jīng)允許翻錄必究.Copyright(C) http://m.facexiu.com, All rights reserved.
          以上信息由企業(yè)自行提供,信息內(nèi)容的真實性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),化工儀器網(wǎng)對此不承擔(dān)任何保證責(zé)任。
          溫馨提示:為規(guī)避購買風(fēng)險,建議您在購買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。
          二維碼 在線交流

          掃一掃訪問手機(jī)站
          湟源县| 连南| 万全县| 卢氏县| 莱阳市| 朔州市| 商洛市| 上林县| 东城区| 顺平县| 洱源县| 富宁县| 苏尼特左旗| 淮阳县| 汝州市| 延边| 闸北区| 泗洪县| 深州市| 广元市| 苏州市| 农安县| 宾阳县| 武威市| 兰坪| 基隆市| 织金县| 房山区| 祁东县| 永登县| 三台县| 太仆寺旗| 保定市| 天峻县| 南乐县| 曲水县| 济阳县| 云龙县| 扶沟县| 义乌市| 新巴尔虎右旗|